📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Safety and tolerability of a novel accelerated dose-escalation regimen of metformin in acute exacerbations of COPD: a multicentre, randomised, double-blind, placebo-controlled trial. (2015)

First Author: Hitchings AW

Attributed to: Developmental Clinical Studies - A clinical trial of metformin in COPD exacerbations funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract

Issue: Not yet known